|Articles|May 1, 2007

Pharmacy Times

  • Volume 0
  • 0

SMOKING AFFECTS WARFARIN THERAPY

Smokingcigarettes canhave a significantimpacton warfarintherapy. Althoughthereis no reportedinteractionbetween nicotineand warfarin,theother chemical compounds that areabsorbed into the body from the smokehave an effect on the liver. The livermakes more enzymes to eliminate thetoxic substances and, in the process,eliminates more warfarin. The end resultof this process is an increase in warfarinrequirements for someone who hasstarted smoking. Warfarin managementcan also be problematic in patients whostop smoking. Ex-smokers should bemonitored carefully after quitting,because their warfarin requirements willlikely be lower. Patients with a knownrecent smoking history who develop anunstable international normalized ratiopattern should be questioned aboutsmoking relapses, since starting andstopping smoking can cause warfarinrequirements to vary. Please see relatedarticle on page 56.

Dr. Garrett is a clinical pharmacist practitioner at Cornerstone Health Carein High Point, NC.

Articles in this issue


Related to this article

Could Linvoseltamab Change When We Treat High-Risk Smoldering Myeloma?
In an interview with Pharmacy Times, LINKER-SMM1 study investigator Paula Rodríguez-Otero, MD, PhD, a hematologist at Clínica Universidad de Navarra in Pamplona, Spain, explains how researchers selected high-risk patients and how she weighs infections against the potential to prevent progression to active disease.